News

Global Infectious Diseases September 8, 2021

When Good T cells Go Bad

In a paper recently published in Immunity, Ragon researchers found that, in these cases, control is lost after a type of immune cell, known as a cytotoxic T cell, loses the ability to proliferate and kill HIV-infected cells.

READ MORE
July 26, 2021

What the Nose Shows: Early Determinants of COVID-19 Severity

Researchers at the Ragon Institute and the Broad Institute showed that the early immune response to SARS-CoV-2, found in the nose, may determine the course of the COVID-19 outcome.

READ MORE
Emerging Infectious Diseases June 4, 2021

New Research Shows Vaccine Protection Against Zika Virus

In a paper published today in the journal Nature, a research team led by scientists at Beth Israel Deaconess Medical Center (BIDMC), in collaboration with scientists at Walter Reed Army Institute of Research (WRAIR) and the University of São Paulo, demonstrates that two different ZIKV vaccine candidates provided complete protection in mice against a ZIKV strain from Brazil and suggest that a ZIKV vaccine for humans will likely be feasible.

READ MORE
HIV June 3, 2021

Engineered to Fight: Dual CAR T cells show promise against HIV

Researchers from the Ragon Institute of MGH, MIT and Harvard and the Perelman School of Medicine at the University of Pennsylvania developed a new Dual CAR T cell immunotherapy that combats HIV infection in humanized mice.

READ MORE

Explore More

About

The Ragon Institute of MGH, MIT and Harvard brings together scientists and engineers from diverse fields to better understand the immune system and support human health.

READ MORE

Administration and Operations

The Administrative and Operations team manages the Ragon’s operations, administrative, and logistical functions.

READ MORE

Community

Our collaborative ethos applies to every aspect of our Institute, and we are committed to being an engaged and involved member of the communities we are fortunate to be a part of.

READ MORE